Try it
General Medicine · Endocrinology: insulin regimens
Sample itemWhich statement about basal-bolus insulin therapy is correct?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. A long-acting analogue like glargine provides basal cover while rapid-acting insulin is given before meals
Basal-bolus regimens mimic physiological insulin secretion, with glargine, detemir or degludec supplying basal needs and aspart, lispro or glulisine covering meals. Glargine has a relatively peakless profile. Rapid analogues are injected just before eating.
Option by option
A. Glargine is given before each meal
Glargine is a once-daily basal insulin.
B. Regular insulin is the only basal agent
Regular insulin is short-acting.
C. A long-acting analogue like glargine provides basal cover while rapid-acting insulin is given before meals (correct)
Correct. This describes basal-bolus therapy.
D. Aspart is a long-acting insulin
Aspart is rapid-acting.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…
- NeurologyA chronic alcohol user is brought in confused, with nystagmus and an unsteady gait. What…